Key points are not available for this paper at this time.
Mutations in BRCA genes cause defects in DNA repair that predict sensitivity to DNA damaging agents, including platinum; however, some patients without BRCA mutations also benefit from these agents. NtAI, a genomic measure of unfaithfully repaired DNA, may identify cancer patients likely to benefit from treatments targeting defective DNA repair.
Building similarity graph...
Analyzing shared references across papers
Loading...
Nicolai J. Birkbak
Zhigang C. Wang
Ji-Young Kim
Cancer Discovery
Brigham and Women's Hospital
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center
Building similarity graph...
Analyzing shared references across papers
Loading...
Birkbak et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69de986c4838c5c0bab0c5f6 — DOI: https://doi.org/10.1158/2159-8290.cd-11-0206